Pretreatment With P2Y12 Inhibitors in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the Swedish Coronary Angiography and Angioplasty Registry.
Juliane JurgaKarolina Elizabeth SzummerChristian LewinterLinda MellbinMatthias GötbergSammy ZwackmanJohan NilssonSebastian VölzDavid ErlingeJonas PerssonElmir OmerovicTomas JernbergDimitrios VenetsanosPublished in: Circulation. Cardiovascular interventions (2021)
In patients with chronic coronary syndrome undergoing coronary angiography and ad hoc percutaneous coronary intervention, pretreatment with P2Y12 inhibitors, before arrival to the catheterization laboratory, was not associated with improved clinical outcomes but was associated with increased risk for bleeding. Our data support clopidogrel administration in the catheterization laboratory as the standard of care. Graphic Abstract: A graphic abstract is available for this article.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- st segment elevation myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery bypass grafting
- coronary artery
- atrial fibrillation
- healthcare
- case report
- coronary artery bypass
- palliative care
- quality improvement
- aortic stenosis
- electronic health record
- pain management
- machine learning
- affordable care act
- ejection fraction
- chronic pain